OMAR WARRAYAT: Open Payments
NPI 1740036516 · ROYAL PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $256 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Janssen Biotech, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, DUPIXENT, RINVOQ, XIFAXAN, XELJANZ.
Industry payments across FL — which companies pay providers there.
